Xencor | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Arrowhead Research USD 570.54M 124.93M 2024-12
AstraZeneca USD 26.14B 312M 2025-03
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Cytokinetics USD 1.11B 89.34M 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
J&J USD 71.55B 15.66B 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 38.78B 1.58B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Xencor USD 577.6M 4.27M 2024-12



Xencor Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.